Come up with a name for your new list and we'll add to it:
Immunovaccine raised a round of funding on , . Investors include
First Angel Network.
IMV develops cancer immunotherapies and infectious disease vaccines based on the Company's DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and a…